ScinoPharm Taiwan Ltd (1789) — Cash Flow Quality Index
ScinoPharm Taiwan Ltd (1789) has a Cash Flow Quality Index of 8.33x as of December 2025. Operating cash flow of NT$343.96 Million exceeds net income of NT$41.28 Million, indicating high earnings quality where cash backs reported profits. Explore ScinoPharm Taiwan Ltd (1789) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ScinoPharm Taiwan Ltd Cash Flow Quality Index (2007–2025)
Historical Cash Flow Quality Index for ScinoPharm Taiwan Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of ScinoPharm Taiwan Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ScinoPharm Taiwan Ltd (2007–2025)
Year-by-year earnings quality comparison for ScinoPharm Taiwan Ltd. For live market cap and the full company financial profile, see ScinoPharm Taiwan Ltd (1789) total market value.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.36x | NT$597.11 Million | NT$136.95 Million | ▲ +139.8% |
| 2024 | 1.82x | NT$750.91 Million | NT$413.02 Million | ▲ +174.4% |
| 2023 | 0.66x | NT$231.13 Million | NT$348.84 Million | ▼ -62.5% |
| 2022 | 1.77x | NT$773.79 Million | NT$437.96 Million | ▲ +4.8% |
| 2021 | 1.69x | NT$509.82 Million | NT$302.29 Million | ▼ -36.1% |
| 2020 | 2.64x | NT$946.31 Million | NT$358.50 Million | ▼ -11.3% |
| 2019 | 2.98x | NT$788.95 Million | NT$265.05 Million | ▲ +18.6% |
| 2018 | 2.51x | NT$1.23 Billion | NT$490.54 Million | ▲ +22.8% |
| 2017 | 2.04x | NT$971.71 Million | NT$475.30 Million | ▼ -0.5% |
| 2016 | 2.05x | NT$1.67 Billion | NT$810.60 Million | ▲ +57.9% |
| 2015 | 1.30x | NT$1.04 Billion | NT$802.88 Million | ▼ -11.8% |
| 2014 | 1.48x | NT$888.29 Million | NT$602.21 Million | ▲ +121.1% |
| 2013 | 0.67x | NT$939.47 Million | NT$1.41 Billion | ▼ -6.8% |
| 2012 | 0.72x | NT$981.55 Million | NT$1.37 Billion | ▼ -46.9% |
| 2011 | 1.35x | NT$1.29 Billion | NT$961.32 Million | ▼ -10.5% |
| 2010 | 1.50x | NT$1.56 Billion | NT$1.04 Billion | ▲ +20.5% |
| 2009 | 1.25x | NT$1.30 Billion | NT$1.04 Billion | ▼ -22.6% |
| 2008 | 1.61x | NT$1.41 Billion | NT$872.11 Million | ▲ +96.2% |
| 2007 | 0.82x | NT$504.50 Million | NT$613.27 Million | — |